Back to Results
First PageMeta Content
Medicine / Clinical research / Design of experiments / Evaluation methods / Bioethics / Riluzole / Amyotrophic lateral sclerosis / Clinical trial / Placebo-controlled study / Pharmacology / Health / Science


MediciNova to Initiate Clinical Trial of MN-166 (ibudilast) in ALS LA JOLLA, Calif., August 25, 2014 (GLOBE NEWSWIRE)-- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and th
Add to Reading List

Document Date: 2014-09-11 11:14:45


Open Document

File Size: 61,79 KB

Share Result on Facebook
UPDATE